O’Hagan joins the Hay-on-Wye, UK-based firm from a major pharma multinational, where she was head of quality assurance. A microbiologist by training, she has broad experience in research and development, production, quality control and quality assurance.
O’Hagan takes responsibility for Brecon’s QA and regulatory activities, and will head a team of Qualified Persons.
‘QPs are in great demand in the industry and I am delighted to be given the opportunity to work with the four QPs at Brecon on the complex task of releasing various companies’ products into the current market. It will be a challenge – but one I am really looking forward to,’ she said.
Brecon appoints director of QA and regulatory affairs
Kay O’Hagan will head a team of Qualified Persons
You may also like
Distribution
CDMOs deliver increased performance for pharma clients with agility and innovation
Emma Verkaik, Membership & Marketing Director at the BCMPA — the Association for Contract Manufacturing, Packing, Fulfilment & Logistics — gleans insights from members in the pharma sector regarding emerging trends, growth opportunities and the impact of increasing digitalisation, sustainability issues and ESG on the wider industry
Manufacturing
Biologics and specialty medicines: planning your packaging from clinic to launch (part I)
The pharmaceutical landscape continues to evolve with an ever-increasing focus on specialty medicines. As a result, supply chains are becoming more elaborate, driven by factors such as cold and ultra-cold chain requirements, the growing complexity of delivery systems and the ever more stringent regulatory requirements associated with the packaging of such products
